Icon (ICLR) Interest & Investment Income (2009 - 2026)
Icon's (ICLR) quarterly Interest & Investment Income came in at $3.2 million in Q2 2026, up 53.6% year-over-year from $2.1 million in Q2 2025, and up 73.26% quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Icon (ICLR) Interest & Investment Income (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Interest & Investment Income for 18 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 53.6% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $8.2 million, a 11.5% decrease from a year earlier, with the FY2025 full-year figure at $7.1 million, down 17.42% from the prior year.
- Interest & Investment Income was $3.2 million for Q2 2026 at Icon, up from $1.8 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.2 million in Q2 2026 and troughed at $127000.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.6 million in 2023 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 2605.66% in 2022, down 50.58% in 2022.
- Over 5 years, Interest & Investment Income stood at $618000.0 in 2022, then surged by 178.32% to $1.7 million in 2023, then soared by 74.88% to $3.0 million in 2024, then slumped by 50.4% to $1.5 million in 2025, then surged by 111.46% to $3.2 million in 2026.
- The last three Interest & Investment Income figures came in at $3.2 million (Q2 2026), $1.8 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.16 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -19.30 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -210,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12,909.62 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 949,000.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 618,000.00 |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 166,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 78,000.00 |
| Sep 30, 2021 | 53,000.00 |